Variation in the gene encoding the serotonin 2A receptor is associated with outcome of antidepressant treatment.
Ontology highlight
ABSTRACT: Depressive disorders account for a large and increasing global burden of disease. Although the condition of many patients improves with medication, only a minority experience full remission, and patients whose condition responds to one medication may not have a response to others. Individual variation in antidepressant treatment outcome is, at present, unpredictable but may have a partial genetic basis. We searched for genetic predictors of treatment outcome in 1,953 patients with major depressive disorder who were treated with the antidepressant citalopram in the Sequenced Treatment Alternatives for Depression (STAR*D) study and were prospectively assessed. In a split-sample design, a selection of 68 candidate genes was genotyped, with 768 single-nucleotide-polymorphism markers chosen to
SUBMITTER: McMahon FJ
PROVIDER: S-EPMC1474035 | biostudies-literature | 2006 May
REPOSITORIES: biostudies-literature
ACCESS DATA